Allergic reaction · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Venous thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Arterial thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Pregnancy loss · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
Heparin plus aspirin may leads to lower pregnancy loss compared with aspirin (low certainty).
1 finding from 1 review
Preterm delivery of a live infant · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether heparin plus aspirin changes preterm delivery of a live infant compared with aspirin (very low certainty).
1 finding from 1 review
Intrauterine growth restriction · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether heparin plus aspirin changes intrauterine growth restriction compared with aspirin (very low certainty).
1 finding from 1 review
Adverse events in the child ‐ Congenital malformations · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Cardiovascular mortality · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin showed no clear difference in cardiovascular mortality compared with aspirin alone (moderate certainty).
1 finding from 1 review
All‐cause mortality · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin showed no clear difference in all‐cause mortality compared with aspirin alone (low certainty).
1 finding from 1 review
Fatal or nonfatal myocardial infarction · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin probably leads to lower fatal and non‐fatal myocardial infarction compared with aspirin alone (moderate certainty).
1 finding from 1 review
Fatal and non‐fatal ischaemic stroke · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin probably leads to lower fatal and non‐fatal ischaemic stroke compared with aspirin alone (moderate certainty).
1 finding from 1 review
Adverse events · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
1 finding from 1 review
Major bleeding · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin probably leads to higher major bleeding compared with aspirin alone (moderate certainty).
1 finding from 1 review
Minor bleeding · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin probably leads to higher minor bleeding compared with aspirin alone (moderate certainty).
1 finding from 1 review
Pain‐free at 2 hours · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pain‐free at different time points (1, 4, 24 hours) · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pain‐free or mild pain at 2 hours · adults with episodic tension‐type headache
1 finding from 1 review
Use of rescue medication · adults with episodic tension‐type headache
1 finding from 1 review
Patient Global Evaluation at end of study · adults with episodic tension‐type headache
1 finding from 1 review
Any adverse event · adults with episodic tension‐type headache
1 finding from 1 review